Tianjin Ringpu Bio Tech (300119) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Tianjin Ringpu Bio Tech (300119) has a cash flow conversion efficiency ratio of 0.020x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥105.02 Million ≈ $15.37 Million USD) by net assets (CN¥5.15 Billion ≈ $753.61 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see 300119 company net worth for the company's overall valuation and market capitalisation.
Tianjin Ringpu Bio Tech - Cash Flow Conversion Efficiency Trend (2007–2025)
This chart illustrates how Tianjin Ringpu Bio Tech's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Tianjin Ringpu Bio Tech Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Tianjin Ringpu Bio Tech ranked by their cash flow conversion efficiency. Explore Tianjin Ringpu Bio Tech cash earnings quality to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Banpu Power Public Company Limited
BK:BPP
|
0.009x |
|
Terveystalo Oy
HE:TTALO
|
0.057x |
|
Bk Harda Internasional Tbk Pt
JK:BBHI
|
0.052x |
|
Bombay Burmah Trading Corporation Limited
NSE:BBTC
|
0.039x |
|
Chengdu Yunda Technology Co Ltd
SHE:300440
|
0.004x |
|
COMPUGROUP MED.SP.ADR 1
F:COPA
|
N/A |
|
Jaiprakash Power Ventures Limited
NSE:JPPOWER
|
0.082x |
|
EFORT Intelligent Equipment Co Ltd
SHG:688165
|
-0.095x |
Annual Cash Flow Conversion Efficiency for Tianjin Ringpu Bio Tech (2007–2025)
The table below shows the annual cash flow conversion efficiency of Tianjin Ringpu Bio Tech from 2007 to 2025. View today's stock price for Tianjin Ringpu Bio Tech for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥5.18 Billion ≈ $758.67 Million |
CN¥297.53 Million ≈ $43.54 Million |
0.057x | -60.94% |
| 2024-12-31 | CN¥5.01 Billion ≈ $732.68 Million |
CN¥735.55 Million ≈ $107.63 Million |
0.147x | +86.64% |
| 2023-12-31 | CN¥4.80 Billion ≈ $703.11 Million |
CN¥378.20 Million ≈ $55.34 Million |
0.079x | -9.04% |
| 2022-12-31 | CN¥4.50 Billion ≈ $658.65 Million |
CN¥389.49 Million ≈ $56.99 Million |
0.087x | -2.22% |
| 2021-12-31 | CN¥4.32 Billion ≈ $632.69 Million |
CN¥382.63 Million ≈ $55.99 Million |
0.088x | -37.64% |
| 2020-12-31 | CN¥2.74 Billion ≈ $400.51 Million |
CN¥388.44 Million ≈ $56.84 Million |
0.142x | -12.80% |
| 2019-12-31 | CN¥2.36 Billion ≈ $344.92 Million |
CN¥383.61 Million ≈ $56.13 Million |
0.163x | +109.80% |
| 2018-12-31 | CN¥2.25 Billion ≈ $329.89 Million |
CN¥174.88 Million ≈ $25.59 Million |
0.078x | +56.93% |
| 2017-12-31 | CN¥2.18 Billion ≈ $318.46 Million |
CN¥107.57 Million ≈ $15.74 Million |
0.049x | -49.89% |
| 2016-12-31 | CN¥2.11 Billion ≈ $308.09 Million |
CN¥207.67 Million ≈ $30.39 Million |
0.099x | -22.55% |
| 2015-12-31 | CN¥1.77 Billion ≈ $258.84 Million |
CN¥225.27 Million ≈ $32.96 Million |
0.127x | +71.20% |
| 2014-12-31 | CN¥1.73 Billion ≈ $252.53 Million |
CN¥128.37 Million ≈ $18.78 Million |
0.074x | +44.29% |
| 2013-12-31 | CN¥1.72 Billion ≈ $251.73 Million |
CN¥88.68 Million ≈ $12.98 Million |
0.052x | -9.05% |
| 2012-12-31 | CN¥1.59 Billion ≈ $232.13 Million |
CN¥89.92 Million ≈ $13.16 Million |
0.057x | -6.07% |
| 2011-12-31 | CN¥1.50 Billion ≈ $218.92 Million |
CN¥90.29 Million ≈ $13.21 Million |
0.060x | -23.68% |
| 2010-12-31 | CN¥1.43 Billion ≈ $208.78 Million |
CN¥112.82 Million ≈ $16.51 Million |
0.079x | -69.09% |
| 2009-12-31 | CN¥252.48 Million ≈ $36.95 Million |
CN¥64.59 Million ≈ $9.45 Million |
0.256x | -6.06% |
| 2008-12-31 | CN¥249.97 Million ≈ $36.58 Million |
CN¥68.07 Million ≈ $9.96 Million |
0.272x | +93.74% |
| 2007-12-31 | CN¥136.21 Million ≈ $19.93 Million |
CN¥19.15 Million ≈ $2.80 Million |
0.141x | -- |
About Tianjin Ringpu Bio Tech
Tianjin Ringpu Bio-Technology Co.,Ltd. engages in the research and development, production, and sale of veterinary raw materials, pharmaceutical preparation, functional additives, and veterinary biological products. The company provides vaccines, chemical drugs, traditional Chinese medicines; feed additives, including pigs, chickens, waterfowl, cattle, sheep and pet medicines, and vaccines; and p… Read more